News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
617,799 Results
Type
Article (43038)
Company Profile (117)
Press Release (574643)
Multimedia
Podcasts (52)
Webinars (13)
Section
Business (175027)
Career Advice (2547)
Deals (31224)
Drug Delivery (109)
Drug Development (76250)
Employer Resources (146)
FDA (14542)
Job Trends (13273)
News (303411)
Policy (29477)
Tag
Academia (2633)
Academic (1)
Accelerated approval (6)
Adcomms (28)
Allergies (91)
Alliances (43496)
ALS (104)
Alzheimer's disease (1446)
Antibody-drug conjugate (ADC) (158)
Approvals (14514)
Artificial intelligence (280)
Autoimmune disease (28)
Automation (18)
Bankruptcy (331)
Best Places to Work (10608)
BIOSECURE Act (20)
Biosimilars (113)
Biotechnology (89)
Bladder cancer (91)
Brain cancer (31)
Breast cancer (334)
Cancer (2638)
Cardiovascular disease (208)
Career advice (2147)
Career pathing (32)
CAR-T (176)
CDC (27)
Cell therapy (473)
Cervical cancer (19)
Clinical research (62603)
Collaboration (894)
Company closure (3)
Compensation (416)
Complete response letters (25)
COVID-19 (2574)
CRISPR (53)
C-suite (305)
Cystic fibrosis (98)
Data (2720)
Decentralized trials (2)
Denatured (8)
Depression (59)
Diabetes (293)
Diagnostics (6144)
Digital health (17)
Diversity (4)
Diversity, equity & inclusion (40)
Drug discovery (126)
Drug pricing (119)
Drug shortages (25)
Duchenne muscular dystrophy (114)
Earnings (67943)
Editorial (41)
Employer branding (21)
Employer resources (134)
Events (93318)
Executive appointments (843)
FDA (15987)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (9)
Funding (805)
Gene editing (119)
Generative AI (20)
Gene therapy (371)
GLP-1 (744)
Government (4321)
Grass and pollen (5)
Guidances (176)
Healthcare (17266)
Huntington's disease (29)
IgA nephropathy (37)
Immunology and inflammation (155)
Immuno-oncology (6)
Indications (33)
Infectious disease (2732)
Inflammatory bowel disease (148)
Inflation Reduction Act (9)
Influenza (58)
Intellectual property (104)
Interviews (534)
IPO (14260)
IRA (46)
Job creations (3036)
Job search strategy (1764)
Kidney cancer (15)
Labor market (31)
Layoffs (471)
Leadership (24)
Legal (6699)
Liver cancer (78)
Lung cancer (388)
Lymphoma (188)
Machine learning (8)
Management (51)
Manufacturing (337)
MASH (91)
Medical device (11624)
Medtech (11628)
Mergers & acquisitions (17582)
Metabolic disorders (755)
Multiple sclerosis (92)
NASH (23)
Neurodegenerative disease (120)
Neuropsychiatric disorders (34)
Neuroscience (2093)
NextGen: Class of 2025 (5916)
Non-profit (4189)
Now hiring (39)
Obesity (379)
Opinion (238)
Ovarian cancer (91)
Pain (101)
Pancreatic cancer (105)
Parkinson's disease (172)
Partnered (20)
Patents (264)
Patient recruitment (129)
Peanut (46)
People (55522)
Pharmaceutical (30)
Pharmacy benefit managers (15)
Phase I (19334)
Phase II (27451)
Phase III (21012)
Pipeline (1526)
Policy (181)
Postmarket research (2442)
Preclinical (8013)
Press Release (72)
Prostate cancer (125)
Psychedelics (38)
Radiopharmaceuticals (239)
Rare diseases (436)
Real estate (4947)
Recruiting (57)
Regulatory (20733)
Reports (30)
Research institute (2232)
Resumes & cover letters (373)
Rett syndrome (9)
RNA editing (7)
RSV (46)
Schizophrenia (88)
Series A (140)
Series B (91)
Service/supplier (6)
Sickle cell disease (57)
Special edition (15)
Spinal muscular atrophy (148)
Sponsored (31)
Startups (3055)
State (2)
Stomach cancer (14)
Supply chain (64)
Tariffs (49)
The Weekly (43)
Vaccines (729)
Venture capitalists (41)
Weight loss (244)
Women's health (30)
Worklife (17)
Date
Today (134)
Last 7 days (477)
Last 30 days (2265)
Last 365 days (29628)
2025 (14087)
2024 (32843)
2023 (36924)
2022 (47873)
2021 (51585)
2020 (49984)
2019 (42769)
2018 (32535)
2017 (29802)
2016 (28711)
2015 (33866)
2014 (26262)
2013 (21667)
2012 (22920)
2011 (24136)
2010 (21976)
Location
Africa (789)
Alabama (53)
Alaska (5)
Arizona (179)
Arkansas (12)
Asia (37113)
Australia (7245)
California (6374)
Canada (2148)
China (601)
Colorado (268)
Connecticut (273)
Delaware (172)
Europe (82584)
Florida (983)
Georgia (208)
Idaho (57)
Illinois (557)
India (26)
Indiana (303)
Iowa (13)
Japan (211)
Kansas (96)
Kentucky (27)
Louisiana (13)
Maine (65)
Maryland (917)
Massachusetts (4687)
Michigan (249)
Minnesota (364)
Mississippi (2)
Missouri (89)
Montana (26)
Nebraska (23)
Nevada (69)
New Hampshire (64)
New Jersey (1866)
New Mexico (22)
New York (1814)
North Carolina (973)
North Dakota (9)
Northern California (2795)
Ohio (200)
Oklahoma (11)
Oregon (26)
Pennsylvania (1341)
Puerto Rico (16)
Rhode Island (31)
South America (1075)
South Carolina (29)
South Dakota (1)
Southern California (2439)
Tennessee (99)
Texas (969)
United States (23821)
Utah (204)
Virginia (169)
Washington D.C. (64)
Washington State (559)
West Virginia (4)
Wisconsin (56)
617,799 Results for "aravive biologics formerly known as ruga corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Averna Therapeutics, formerly known as Exsilio Therapeutics, Appoints Thomas M. Barnes, Ph.D., as Chief Executive Officer
January 27, 2025
·
3 min read
Breast cancer
AstraZeneca, Daiichi Sankyo’s ADC Wins First Approval Despite Mixed Data
Datroway, formerly known as Dato-DXd, significantly improved median progression-free survival in a Phase III study but failed to do so for overall survival.
January 21, 2025
·
2 min read
·
Tristan Manalac
Press Releases
NurExone Biologic Inc. Announces First Quarter 2025 Financial Results and Provides Corporate Update
May 27, 2025
·
13 min read
Press Releases
Solvias to Speak at Festival of Biologics 2025 on Building Robust CMC Assays for Biologic Therapies
April 23, 2025
·
2 min read
Vaccines
As New CDC Vaccine Advisors Gear Up for First Meeting, Experts Ask, ‘Where’s Cassidy?’
Scientists and analysts express concern that the newly appointed ACIP members—which include known anti-vaxxers—could relitigate recommendations that have already been made. Many are imploring Sen. Bill Cassidy to step up.
June 12, 2025
·
4 min read
·
Heather McKenzie
Press Releases
Celltrion’s Remdantry™, previously known as Inflectra®, will be available in Canada as of April 1, 2025
March 27, 2025
·
3 min read
Press Releases
Turnstone Biologics Corp. Reports First Quarter 2025 Financial Results and Provides Recent Corporate Highlights
May 9, 2025
·
4 min read
Press Releases
Biocon Biologics and Civica, Inc. Collaborate to Expand Insulin Aspart Access in the United States
March 7, 2025
·
6 min read
Business
Aravive Reports First Quarter 2023 Financial Results and Provides Corporate Updates
Aravive, Inc. (Nasdaq: ARAV, “the Company”), a late clinical-stage oncology company developing targeted therapeutics to treat metastatic disease, today reported first quarter 2023 financial results and provided corporate updates.
May 10, 2023
·
12 min read
Duchenne muscular dystrophy
UPDATE: Second Patient Dies After Receiving Sarepta’s DMD Gene Therapy Elevidys
Sarepta’s shares crashed 41% in pre-market trading Monday morning to $21.01 after the biotech reported a second death from acute liver failure, a known side effect of adeno-associated virus-based gene therapies.
June 16, 2025
·
3 min read
·
Tristan Manalac
1 of 61,780
Next
